After treating ICI-182780, a tiny reduction of ERα could be observed than that in breast cancer cells; it might due to the cell type specificity and not be a common phenomenon due to genetic background of SH-SY5Y cells different from breast cancer cells. Here, ESR1 is linked to breast cancer.